-+ 0.00%
-+ 0.00%
-+ 0.00%

Roche’s Genentech invests $2 billion in first East Coast manufacturing plant in North Carolina

PUBT·08/18/2026 19:40:30
Listen to the news
Roche’s Genentech invests $2 billion in first East Coast manufacturing plant in North Carolina
  • Roche will invest about USD 2 billion to build Genentech’s first East Coast manufacturing site in Holly Springs, North Carolina.
  • Project reached a topping-out milestone with the final structural beam placed, keeping construction on schedule.
  • Site will manufacture next-generation metabolic medicines, including obesity treatments, using automation, robotics, digital manufacturing, and an AI-powered digital twin.
  • Facility is expected to support over 2,000 jobs, including more than 500 manufacturing roles.
  • Investment forms part of Roche and Genentech’s USD 50 billion U.S. R&D and manufacturing infrastructure commitment.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Roche Holding AG published the original content used to generate this news brief via Business Wire (Ref. ID: 20260818249816) on August 18, 2026, and is solely responsible for the information contained therein.